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Background: There are few studies of the effects of nasal snuff and environmental factors on the risk of nasal
cancer. This study aimed to investigate the impact of using nasal snuff and of other risk factors on the risk of nasal
cancer in German men.
Methods: A population-based case–control study was conducted in the German Federal States of Bavaria and
Baden-Württemberg. Tumor registries and ear, nose and throat departments provided access to patients born in
1926 or later.
Results: Telephone interviews were conducted with 427 cases (mean age 62.1 years) and 2.401 population-based
controls (mean age 60.8 years). Ever-use of nasal snuff was associated with an odds ratio (OR) for nasal cancer of
1.45 (95% confidence interval [CI] 0.88–2.38) in the total study population, whereas OR in smokers was 2.01 (95%
CI 1.00-4.02) and in never smokers was 1.10 (95% CI 0.43–2.80). The OR in ever-smokers vs. never-smokers was
1.60 (95% CI 1.24–2.07), with an OR of 1.06 (95% CI 1.05–1.07) per pack-year smoked, and the risk was significantly
decreased after quitting smoking. Exposure to hardwood dust for at least 1 year resulted in an OR of 2.33 (95%
CI 1.40–3.91) in the total population, which was further increased in never-smokers (OR 4.89, 95% CI 1.92–12.49) in
analyses stratified by smoking status. The OR for nasal cancer after exposure to organic solvents for at least 1 year
was 1.53 (1.17–2.01). Ever-use of nasal sprays/nasal lavage for at least 1 month rendered an OR of 1.59 (1.04–2.44).
The OR after use of insecticides in homes was 1.48 (95% CI 1.04–2.11).
Conclusions: Smoking and exposure to hardwood dust were confirmed as risk factors for nasal carcinoma. There is
evidence that exposure to organic solvents, and in-house use of insecticides could represent novel risk factors.
Exposure to asbestos and use of nasal snuff were risk factors in smokers only.
Keywords: Case–control study, Nasal cancer, Smoking, Hardwood dust, Asbestos, Organic solvents, Insecticides,
Nasal spray, Nasal lavage, Nasal snuffBackground
It is generally agreed that all kind of tobacco products
are both addictive and carcinogenic. This also includes
smokeless tobacco products [1,2]. There are, however,
few publications investigating the association between
the use of snuff and nasal cancer.
In a case series of cancers of the paranasal sinuses
(CPNS) in Bantu males from Transvaal, South Africa, 22
out of 28 had used nasal snuff for a prolonged time [3].* Correspondence: eberhard.greiser@arcor.de
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reproduction in any medium, provided the orIn another case series [4] on cancers of the nasal cavity
(CNC) and CPNS in the boot and shoe industry in
Northamptonshire, Great Britain, eight out of 26 patients
were nasal snuff users.
In three subsequent publications, results of case–
control studies have been reported.
In a case–control study including 160 patients with
CNC or CPNS and 290 hospital controls from four hos-
pitals in North Carolina and Virginia, an increased haz-
ard ratio of 1.47 (95% confidence interval [CI] 0.8–2.8)
for use of snuff was detected [5]. A case–control study
from the Florida Cancer Registry was based on 71 cases
of nasopharyngeal cancer (NPC), on 92 cases of CPNSLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to tobacco use [6]. The reported odds ratios (OR) for
use of snuff were 5.3 (95% CI 0.7–41.6) for NPC and 3.3
(95% CI 0.4–25.9) for CNC/CPNS. However, in the Uni-
ted States, snuff is often taken orally, so the results
of the latter two case–control studies provide only
marginal evidence for estimating the risks of nasal use
of snuff.
A recent case–control study from North Africa
(Algeria, Morocco, Tunisia) [7] reported on the impact
of tobacco and cannabis use on NPC risk in 636 cases
and 625 hospital/family/neighborhood controls. The OR
for ever-use of snuff, either orally or nasally, for all
histologic types of nasal cancer was 1.03 (95% CI 0.64–
1.65), but was 30.2 (95% CI 1.67–546) for differentiated
carcinomas. The latter result is obviously based on very
few cases, as indicated by the extremely large CI.
We conducted a population-based case–control study
to investigate the impact of nasal snuff on the risk of
CNC, CPNS and NPC. Simultaneously we analyzed the
potential impact of individual, environmental and occu-
pational risk factors for this group of malignancies.
The study was conducted by the Bremen Institute
for Prevention Research and Social Medicine (BIPS),
Bremen, Germany.
Methods
Sales figures provided by a major manufacturer indicated
that the use of nasal snuff in Germany was most preva-
lent in two Southern Federal States of Germany, Bavaria
and Baden-Württemberg, thus these areas were chosen
as the study region. The study design was approved by
the Ethical Review Committees of the Bremen State
Chamber of Physicians, of the Bavarian State Chamber
of Physicians, of the Baden-Württemberg State Chamber
of Physicians, of Augsburg Central Hospital, and of
Tübingen University Hospital. Design, conduct and
analysis of the study were overseen by an independent
scientific advisory board (see Appendix). Cases were
restricted to male patients born after 1925 with primary
CNC, CPNS, or NPC. Diagnoses were confirmed histolo-
gically starting January 1, 1990, and cases were recruited
retrospectively. Access to patients was achieved through
clinical tumor registries in Bavaria, and through ear, nose
and throat (ENT) departments in all hospitals treating
such patients in Baden-Württemberg. Histopathologic
findings for each case were provided by the respective
tumor registry or by ENT departments. In both federal
states, the ENT departments sought written consent
from patients to participate in telephone interviews. In
hospitals without a link to a clinical tumor registry,
archives of hospital records were perused by hospital
staff to identify eligible patients. Age-matched controls
were drawn from community residency registries ofcommunities with resident cases or of communities
of comparable size within the same federal state. As resi-
dency registries comprise in each German community
the complete resident population, the community admi-
nistrators were asked for a random sample of resident
males with sample characteristics specified by number
for each age. It was not possible to reconstruct the status
of residency registries according to the year of diagnosis
of cases. Sample size was calculated for a prevalence of
0.12 to allow for detection of ORs of 1.4 with type I and
type II errors of 0.05 and 0.80, respectively. This sug-
gested 700 cases and 2100 controls with 1:3 frequency
matching for year of birth +/- 2 years. During the first
phase of the study it became obvious that a sample of
700 cases could not be reached, but the calculated num-
ber of controls was adhered to. The calculated OR did
not change to a relevant extent, but it was assumed that
the precision regarding confounders would increase.
The questionnaire consisted of sociodemographic vari-
ables, lifetime occupational history, use of nasal snuff,
smoking, exposure to environmental tobacco smoke, dis-
eases of the nose, previous malignancies, family history
of malignancies, nutritional habits including consump-
tion of alcohol, specific exposures (use of insecticides in
homes, organic solvents). Lifetime occupational history
included each occupational period by year, line of busi-
ness, job title and specific exposures (solvents, radio-
active substances, radiation, asbestos, dusts). Additional
questions were added for work in forestry, farming, car-
pentry, and metal-working. For each of these occupa-
tions, specific exposures were assessed by duration and
type of exposures, e.g., in carpentry for type of wood
(softwood, hardwood, chipboard wood).
During a pilot study, face-to-face interviews were con-
ducted in cases of the Munich Tumor Registry. Logistic
considerations led to the decision to use telephone inter-
views for the main study. A computer-assisted telephone
interview system with trained and supervised female
interviewers was used. Interviews of next-of-kin of
deceased cases were attempted with a modified ques-
tionnaire. During the course of the study it became obvi-
ous that some of the cases had speech impediments
owing to surgical therapy. These cases (n = 36) were
provided with printed questionnaires by mail. Another
case could not provide a telephone number and received
a printed questionnaire subsequently. After completion
of the pilot study, the Scientific Advisory Board sug-
gested a modification of the food frequency list.
Statistical analyses were performed using SAS 9.2
(SAS Institute, Cary, NC, USA). for tabulation of study
characteristics (Proc Summary) and for multivariate lo-
gistic regression (Proc Phreg). Assuming a linear dose–
response relationship, logistic regression analyses for
continuous independent variables were conducted in
Table 1 Major characteristics of the study population
Year of birth Cases (%) Controls (%)
< 1930 292 (12.2) 63 (14.8)
1930–39 859 (35.8) 160 (37.5)
1940–49 577 (24.0) 96 (22.5)
1950–59 367 (15.3) 64 (15.0)
1960–69 199 (8.3) 37 (8.7)
1970+ 107 (4.5) 7 (1.6)
Total 427 (100.0) 2.401 (100.0)
Community size
< 5.000 134 (31.4) 728 (30.3)
5.000 < 10.000 83 (19.4) 435 (18.1)
10.000 < 100.000 127 (29.7) 739 (30.8)
100.000+ 83 (19.4) 499 (20.8)
Chi2 = 0.92/p=0.82
Educational attainment
Primary school or less 289 (67.7) 1329 (55.4)
Secondary school 77 (18.0) 625 (26.0)
College 61 (14.3) 447 (18.6)
Chi2 = 22.8/p ≤0.0001
Site of malignancies
Nasal cavity 112 -
Paranasal sinuses 135 -
Nasopharynx 180 -
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(pack-years for smoking [i.e., smoking one pack per day
for 1 year], package-years for nasal snuff [i.e. using one
package per week for 1 year]), exposure years (for hard-
wood dust, organic solvents, asbestos, use of nasal sprays
or nasal lavage), and quartiles of exposure. Additional
analyses included stratification by smoking status. Ad-
justment for potential confounders included: year of
birth; community size; educational attainment; cigarette
pack-years; nasal snuff package-years; years of exposure
to hardwood dust, asbestos, or organic solvents; use
of nasal spray/nasal lavage; and ever-use of insecticides
in homes.
Results
Altogether, 917 potential cases were identified. After
classifying these by location and histopathologic find-
ings, 707 patients met the inclusion criteria. Interviews
could be conducted with 389 (55%) of these patients,
and 38 interviews of cases conducted during the pilot
phase were added to the final database. Three of these
cases had to be re-interviewed for application of add-
itional occupational exposure questionnaires. Addresses
of 4.207 potential controls were drawn from residency
registers in Bavaria and Baden-Württemberg. Of these
addresses 165 of these were no longer valid, another
68 persons were deceased. When being contacted for
interviews 99 persons declined due to physical impair-
ment. Finally 2 of the potential controls were patients
who met inclusion criteria as cases. They were included
as cases, after histopathologic findings had been pro-
vided by their respective hospitals. Of 3.873 eligible con-
trols 2.401 interviews were completed, giving a response
rate of 62.0%. The final study population consisted of
427 cases (mean age 62.1 [standard deviation 11.9 years])
and of 2401 controls (mean age 60.8 years [standard
deviation 12.9 years]). The major characteristics of the
study population are presented in Table 1. Cases had sig-
nificantly lower educational attainment than controls.
Most of the tumors originated from the nasopharynx
(n = 181, 42.4%) followed by the paranasal sinuses (n =
159, 37.2%) and the nasal cavity (n = 87, 20.4%). Results
by location of the respective tumors are reported in
brief; detailed results by malignancy location as well
as by histologic classification will be published in a sep-
arate paper.
Nasal snuff
Table 2 presents the analyses of the use of nasal snuff
and the risk of nasal cancer. There was a significantly
increased risk for the 4th quartile of snuff package-years
(OR 2.41, 95% CI 1.13–5.15) compared with never-users
of nasal snuff. Stratified analyses by smoking status
showed a divergent picture. In never-smokers there wasno increase in risk in any of the analyses of snuff use. In
smokers, the risk increased in ever-use of snuff (OR
2.01, 95% CI 1.00–4.02), per year of snuff use (OR 1.02,
95% CI 1.01–1.04), and in the 4th quartile of snuff
package-years (OR 6.91, 95% CI 2.31–20.7). Regarding
tumor site, the increases in risk were exclusively in
tumors of the paranasal sinuses (ever-use: OR 3.19, 95%
CI 1.46–6.96; ever-use in smokers: OR 8.23, 95% CI
2.23–34.91; increase per year of use in all subjects:
OR 1.01, 95% CI 1.00–1.02; in smokers: OR 1.03, 95%
CI 1.01–1.05).Smoking
Cigarette smoking emerged as a strong risk factor for
nasal cancer in all parameters analyzed (Table 3).
There was a 60% increase in risk in ever-smokers
(95% CI 24–107%), and an increase of 6% per pack-year
(95% CI 5–7%). Similar risk increases were found for
tumors in all sites (data not shown).
Analyses by quartiles of pack-years of cigarette smok-
ing showed a peak OR of 4.11 (95% CI 3.01-5.62) in the
4th quartile (exposure to 21.75 pack-years or more).
When investigating the impact of quitting cigarette
smoking there was an obvious decrease from an OR of
1.11 (95% CI 0.69-1.79) in smokers quitting less than
Table 2 Association of nasal snuff and smoking with nasal malignancies
Controls (%) Cases (%) OR (95% CI)
All study participants
Reference* 2273 (94.7) 399 (93.4) 1.00
Nasal snuff (ever) 128 (5.3) 28 (6.6) 1.45 (0.88–2.38)
Nasal snuff package-years§ 128 (5.3) 28 (6.6) 1.01 (1.00–1.02)
Snuff package-years (quartiles) < 2 31 (1.3) 2 (0.5) 0.52 (0.10–2.68)
2 < 4 27 (1.3) 5 (1.2) 1.16 (0.36–3.75)
4 <12.5 37 (1.1) 9 (2.1) 1.29 (0.53–3.12)
12.5+ 33 (1.4) 12 (2.8) 2.41 (1.13–5.15)
Smokers
Reference* 1333 (94.2) 272 (93.2) 1.00
Nasal snuff (ever) 82 (5.8) 20 (6.8) 2.01 (1.00–4.02)
Nasal snuff package-years§ 82 (5.8) 20 (6.8) 1.02 (1.01–1.04)
Snuff package-years(quartiles) < 2 16 (1.1) 1 (0.3) 0.60 (0.04–8.33)
2 < 4 19 (1.3) 3 (1.0) 0.75 (0.11–4.96)
4 <12.5 26 (1.8) 7 (2.4) 1.36 (0.44–4.25)
12.5+ 21 (1.5) 9 (3.1) 6.91 (2.31–2 0.69)
Never-smokers
Reference* 940 (95.3) 127 (94.1) 1.00
Nasal snuff (ever) 46 (4.7) 8 (5.9) 1.10 (0.43–2.80)
Nasal snuff package-years§ 46 (4.7) 8 (5.9) 1.00 (0.98–1.02)
* never used nasal snuff.
§ One package-year = use of 1 package per week for one year.
Adjustments: Year of birth, community size, educational attainment, cigarette packyears (all study participants only), exposure to hardwood dust, asbestos, organic
solvents, use of nasal spray/nasal lavage and ever-use of insecticides in homes.
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those who quit 28 or more years ago.
Exposure to wood dust
We analyzed exposure to softwood dust, chipboard dust,




Smoking (ever) 1415 (58.9)
Smoking (per pack-year) 1415 (58.9)
Pack-years (quartiles) <8.6 352 (14.7)
8.6 < 14.5 345 (14.4)




Duration since quitting (tertiles) <15 years 158 (10.4)
15–27 years 175 (11.5)
28+ years 199 (13.1)
* Non-smokers.
Adjustments: Year of birth, community size, educational attainment, nasal snuff pac
use of nasal spray/nasal lavage and ever-use of insecticides in homes.no increased risk after exposure to softwood dust or
chipboard dust (OR for exposure for at least 1 year: soft-
wood dust 0.51 [95% CI 0.25–1.05]; chipboard dust 0.66
[95% CI 0.25–1.72]). Ever-exposure to hardwood dust
resulted in a doubling of risk (OR 2.33, 95% CI 1.40–
3.91) with an increase per year of exposure of 6% (95%) Cases (%) OR (95% CI)
135 (31.6) 1.00
292 (68.4) 1.60 (1.24–2.07)
292 (68.4) 1.06 (1.05–1.07)
36 (8.4) 0.53 (0.35–1.18)
32 (7.5) 0.67 (0.42–1.06)
49 (11.5) 1.05 (0.70–1.58)
175 (41.0) 4.11 (3.01–5.62)
135 (70.6) 1.00
22 (11.5) 1.11 (0.69–1.79)
22 (11.5) 1.13 (0.73–1.75)
12 (6.3) 0.44 (0.26–0.74)
kage-years, years of exposure to hardwood dust, asbestos, organic solvents,
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found a significant increase of 6% (95% CI 3–8%) in
malignancies of the paranasal sinuses and of 4% in
malignancies of the nasal cavity (95% CI 1–7%). In
analyses stratified by smoking status, never-smokers
had much larger risk increases than smokers, display-
ing a nearly 5-fold increase for ever-exposure to hard-
wood dust (OR 4.89, 95% CI 1.92–12.49) and a 6-fold
increase in those exposed for 24 years or more
(OR 6.09, 95% CI 1.56–23.75). The risks in smokers
of exposure to hardwood dust were lower (ever-
exposure OR 2.42, 95% CI 1.103–5.68 and exposure
for 24+ years OR 4.04, 95% CI 1.2313.2) for
24+ years OR 8.69, 95% CI 1.36–55.42). Analysis by
histologic classification showed that increased risks
were exclusively for adenocarcinomas (exposed for at
least 1 year: OR 18.98, 95% CI 8.24–43.71).
Asbestos
In the total study population, there was only a mar-
ginally significant increased risk per year of asbestos
exposure in cases with primary malignancy localized
in the paranasal sinuses (OR 1.03, 95% CI 1.00–1.06).
In smokers, the OR per year of exposure to asbestos




Exposed for at least 1 year§ 70 (2.9)
Per year of exposure§ 70 (2.9)
Exposure (tertile) < 8 years 23 (1.0)
8 < 24 years 23 (1.0)
24+ years 24 (1.0)
Smokers
Reference* 1370 (96.8)
Exposed for at least 1 year§ 45 (3.2)
Per year of exposure§ 45 (3.2)
Exposure (tertile) < 8 years 16 (1.1)
8 < 24 years 16 (1.1)
24+ years 13 (0.9)
Never-smokers
Reference* 961 (97.5)
Exposed for at least 1 year§ 25 (2.5)
Per year of exposure§ 25 (2.5)
Exposure (tertile) < 8 years 7 (0.7)
8 < 24 years 7 (0.7)
24+ years 11 (1.1)
*never exposed to hardwood dust.
§daily/several days per week.
Adjustments: Year of birth, community size, educational attainment, cigarette pack-
asbestos, organic solvents, use of nasal spray/nasal lavage and ever-use of insecticidincrease across tertiles of exposure duration up to an OR
of 2.30 (95% CI 1.17-4.53) in those exposed for 14 years or
longer. Significant increases were found in malignancies
of the paranasal sinuses and of the nasopharynx (per year
of exposure: OR 1.06, 95% CI 1.01–1.13 and OR 1.05, 95%
CI 1.01–1.10, respectively). In never-smoking men,
no statistically significant increase in risk of exposure to
asbestos was found.
Organic solvents
Exposure to organic solvents was determined both by ques-
tions about exposure during any occupation as well as by a
detailed questionnaire module about specific tasks in
metal-work. Using these questionnaire moduls we could
not detect any correlation with nasal cancer, but the num-
bers were too low to make firm conclusions. The more gen-
eral questions, however, indicated an increase in risk for
ever-exposure to organic solvents of 56% (95% CI 17–
101%), with an increase per year of exposure of 2% (95% CI
1–3%) (Table 6). A similar risk increase applied to malig-
nancies of the nasal cavity and of the paranasal sinuses, but
not to nasopharyngeal carcinomas.
The results of an analysis by tertiles of exposure years
indicated a possible bimodal distribution of risk, as only
the first and third tertiles had significantly increasedl malignancies
Cases (%) OR (95% CI)
393 (92.0) 1.00
34 (8.0) 2.33 (1.40–3.91)
34 (8.0) 1.06 (1.03–1.10)
6 (1.4) 2.08 (0.56–7.74)
9 (2.1) 1.26 (0.51–3.18)
19 (4.5) 13.07 (3.44–49.70)
273 (93.5) 1.0
19 (6.5) 2.42 (1.03–5.68)
19 (6.5) 1.07 (1.02–1.12)
4 (1.4) 2.72 (0.56–13.14)
5 (1.7) 1.65 (0.53–5.18)
10 (3.4) 8.69 (1.36–55.42)
120 (88.9) 1.00
15 (11.1) 6.09 (1.56–23.75)
15 (11.1) 1.09 (1.02–1.16)
2 (1.5) 2.84 (0.24–34.27)
4 (3.0) 3.20 (0.34–30.07)
9 (6.7) 22.25 (2.05–241.02)
years (all study participants), snuff package-years, years of exposure to
es in homes, duration of exposure to softwood dust and to chipboard dust.
Table 5 Association of exposure to asbestos with nasal malignancies
Controls (%) Cases (%) OR (95% CI)
All study participants
Reference* 2105 (87.7) 360 (84.3) 1.0
Ever exposed for at least 1 year§ 296 (12.3) 67 (15.7) 0.81 (0.47–1.39)
Per year of exposure§ 296 (12.3) 67 (15.7) 1.02 (1.00–1.04)
Exposure (tertiles) < 5 years 92 (3.8) 11 (2.6) 0.55 (0.24–1.24)
5 < 14 years 106 (4.4) 26 (6.1) 1.13 (0.56–2.28)
14+ years 98 (4.1) 30 (7.0) 1.34 (0.32–5.59)
Smokers
Reference* 1237 (87.4) 246 (84.5) 1.0
Ever exposed for at least 1 year§ 178 (12.6) 46 (15.8) 1.23 (0.74–1.91)
Per year of exposure§ 178 (12.6) 46 (15.8) 1.03 (1.01–1.06)
Exposure (tertiles) < 5 years 58 (4.1) 8 (2.7) 0.75 (0.31–1.84)
5 < 14 years 66 (4.7) 14 (4.8) 0.93 (0.48–1.84)
14+ years 54 (3.8) 24 (8.2) 2.30 (1.17–4.53)
Never-smokers
Reference* 868 (88.0) 114 (84.4) 1.0
Ever exposed for at least 1 year§ 118 (12.0) 21 (15.6) 0.41 (0.08–2.03)
Per year of exposure§ 118 (12.0) 21 (15.6) 1.17 (0.42–3.28)
Exposure (tertiles) < 5 years 34 (3.4) 3 (2.2) 0.59 (0.15–2.28)
5 < 14 years 40 (4.1) 12 (8.9) 1.17 (0.42–3.28)
14+ years 44 (4.5) 6 (4.4) 0.60 (0.15–2.29)
* never exposed to asbestos.
§daily/several days per week.
Adjustments: Year of birth, community size, educational attainment, pack-years (all study participants), snuff package-years, years of exposure to hardwood dust,
organic solvents, use of nasal spray/nasal lavage and ever-use of insecticides in residences.
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2.58], respectively). Stratified analyses by smoking status
indicated an even higher increase in risk in smokers, but
no increased risk in never-smokers.
Other risk factors
Prolonged use of nasal sprays, nasal drops or nasal lav-
age, i.e., daily use for at least 1 month, was associated
with an increased risk of nasal cancer (OR 1.59, 95% CI
1.04–2.44; Table 7). This risk was obvious in the naso-
pharynx only (ever use: OR 2.2, 95% CI 1.27–4.07; per
year of use: OR 1.04, 95% CI 1.01–1.08). A history
of diseases of the nose and of the paranasal sinuses was
not associated with any increase in risk. Malignancies
of any kind in next-of-kin were not associated with
nasal cancer.
Occupational use of herbicides and insecticides, ascer-
tained by detailed survey questionnaire modules for oc-
cupation as farmer, gardener or forester, was not
associated with any increase in risk of nasal cancer. In
contrast to these findings, ever-use of insecticides in pri-
vate residences was associated with a nearly 50% in-
crease in nasal cancer in the total study population (OR
1.48, 95% CI 1.04–2.11; Table 7), and was mainly due to
an increase in malignancies of the nasopharynx (OR1.80, 95% CI 1.08–3.00). In smokers, the increase in risk




We could identify six studies [3-8] that dealt with snuff
as a potential risk factor for malignancies of the nasal
cavity, paranasal sinuses and nasopharynx, four of which
were case-control studies [5-8]. These studies, however,
all had some specific limitations. Either the composition
of snuff contained several other potentially toxic sub-
stances besides tobacco powder (3,7) or “snuff” related
both to snuff used nasally as well as orally or exclusively
orally (5-8).
Regarding CNC and CPNS, our study was larger than
the above-mentioned studies and, in addition, adjust-
ment was achieved for a variety of potential risk factors.
When combining all cancer sites and controlling for
additional risk factors, we found an increased risk of
nasal cancer for use of nasal snuff nearly identical to that
reported by Brinton et al. (OR 1.47, 95% CI 0.8–2.8 vs.
OR 1.45, 95% CI 0.88–2.38 in our study). The OR
increased to 1.71 (95% CI 0.91–3.21) when we restricted
the analysis to CPNS. Subgroup analyses in our study
Table 6 Association of organic solvent exposure with nasal malignancies
Controls (%) Cases (%) OR (95% CI)
All study participants
Reference* 1815 (75.6) 281 (65.8) 1.0
Ever exposed for at least 1 year§ 586 (24.4) 146 (34.2) 1.56 (1.17–2.01)
Per year of exposure§ 586 (24.4) 146 (34.2) 1.02 (1.01–1.03)
Exposure (tertiles) < 7 years 198 (8.2) 44 (10.3) 1.57 (1.03–2.38)
7 < 20 years 183 (7.6) 37 (8.7) 1.23 (0.77–1.96)
20+ years 205 (8.5) 65 (15.2) 1.75 (1.19–2.58)
Smokers
Reference* 1064 (75.2) 185 (63.4) 1.00
Ever exposed for at least 1 year§ 351 (24.8) 107 (36.6) 1.95 (1.34–2.83)
Per year of exposure§ 351 (24.8) 107 (36.6) 1.02 (1.01–1.04)
Exposure (tertiles) < 7 years 123 (8.7) 31 (10.6) 2.08 (1.19–3.65)
7 < 20 years 116 (8.2) 25 (8.6) 1.45 (0.76–2.77)
20+ years 112 (7.9) 51 (17.5) 2.24 (1.31–3.82)
Never-smokers
Reference* 751 (76.2) 96 (71.1) 1.00
Ever exposed for at least 1 year§ 235 (23.8) 39 (28.9) 1.06 (0.61–1.84)
Per year of exposure§ 235 (23.8) 39 (28.9) 0.99 (0.97–1.02)
Exposure (tertiles) < 7 years 75 (7.6) 13 (9.6) 1.98 (0.84–4.65)
7 < 23 years 80 (8.1) 14 (10.4) 0.61 (0.22–1.67)
23+ years 80 (8.1) 12 (8.9) 0.96 (0.44–2.11)
*never exposed to organic solvents.
§daily/several days per week.
Adjustments: Year of birth, community size, educational attainment, pack-years (all study participants), snuff package-years, years of exposure to hardwood dust,
asbestos, use of nasal spray/nasal lavage and ever-use of insecticides in residences.
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probably were restricted to users of nasal snuff who were
former smokers or who were currently smoking. If there
is any increased cancer risk in non-smokers, it is likely
to be considerably smaller than in smokers. However,
because of the relatively small subgroup of never-
smokers in our study (135 cases and 986 controls), the
power to detect such a risk might have been too small.
Power calculations showed that an OR of 2.0 could be
detected with such a sample size. A comparison of
package-years of snuff by smoking status shows that
never-smoking controls used 19.5 package-years of nasal
snuff compared with 17.81 in cases, whereas smoking
controls used 14.56 package-years vs. 27.08 in cases.
Interestingly, the Expert Committee convened by the
International Agency for Research on Cancer, which in
2004 reviewed the available scientific evidence for the
carcinogenicity of smokeless tobacco [1, p. 366], came to
the conclusion: “Studies on nasal use of snuff did not pro-
vide conclusive evidence of a relationship with cancer.”
Smoking
Smoking as a risk factor for nasal cancer has been inves-
tigated by several groups [5-22]. All risk increases
reported in these studies, either for ever-smoking or forquartiles of pack-years, were well within the range
observed in our study. There were, however, some stud-
ies reporting no increase in risk of nasal cancer from
smoking [7,23-25]. The impact of quitting smoking has
been analyzed in only a few studies [10,13,14], but in
none of these publications was the decrease in risk sig-
nificant. In contrast, our study showed a clear decrease
in risk from an OR of 1.11 (95% CI 0.69-1.79) in smo-
kers who quit less than 15 years ago to an OR of 0.44
(95% CI 0.26-0.74) in smokers who quit 28 or more
years previously. As the risk was considerably smaller
than that for non-smokers, it is possible that men who
quit smoking and abstained from smoking for a longer
period not only changed from smoking to non-smoking
but may also have improved other aspects of their life-
style (nutrition, physical activity).
Hardwood dust
Exposure to hardwood dust is a well established risk fac-
tor for the development of adenocarcinoma of the nasal
cavities [25,26]. Although Blot and co-authors [27], in a
review of North American studies, found marginally sig-
nificant increases in risk, probably as a result of very few
exposed cases, other studies showed significantly
increased risks or much larger risk ratios [9,28-34], and
Table 7 Other risk factors associated with nasal malignancies
Use of nasal lavage/nasal sprays Controls (%) Cases (%) OR (95% CI)
All study participants
Reference* 2.196 (91.5) 381 (89.2) 1.0
Ever use daily for at least 1 month 205 (8.5) 46 (10.8) 1.59 (1.04–2.44)
Per year of use 205 (8.5) 46 (10.8) 1.01 (.98–1.04)
Smokers
Reference* 1.296 (91.6) 265 (91.1) 1.00
Ever use daily for at least 1 month 119 (8.4) 27 (9.3) 1.70 (.92–3.14)
Per year of use 119 (8.4) 27 (9.3) 1.01 (.97–1.05)
Never-smokers
Reference* 900 (91.3) 116 (85.9) 1.00
Ever use daily for at least 1 month 86 (8.7) 19 (14.1) .89 (.37–2.13)
Per year of use 86 (8.7) 19 (14.1) .98 (.92–1.04)
Use of insecticides in homes
All study participants
Reference§ 2126 (88.5) 351 (82.2) 1.00
Ever use 275 (11.5) 76 (17.8) 1.48 (1.04–2.11)
Smokers
Reference§ 1226 (86.6) 238 (81.5) 1.00
Ever use 189 (13.4) 54 (18.5) 1.17 (0.71–1.91)
Never-smokers
Reference§ 900 (91.3) 113 (83.7) 1.00
Ever use 86 (8.7) 22 (16.3) 1.78 (.84–3.78)
* never used nasal sprays/nasal lavage daily for 1 month.
§ never used domestic insecticides.
Adjustments: nasal lavage/nasal sprays: year of birth, community size, educational attainment, pack-years (total population & smokers), snuff package-years, years
of exposure to hardwood dust, asbestos, organic solvents, domestic use of insecticides.
Adjustments: domestic use of insecticides: year of birth, community size, educational attainment, pack-years (total population & smokers), snuff package-years,
years of exposure to hardwood dust, asbestos, organic solvents, use of nasal spray/nasal lavage.
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[30-32]. Our study showing an OR of 2.33 for exposure
of at least 1 year (95% CI 1.40–3.91) as well as an
increase over tertiles of exposure years from 1.04 to 5.34
(95% CI 2.55–11.20) is well in agreement with the latter
studies. When stratifying our analyses by smoking status
we found larger risks in never-smokers than in smokers.
This suggests a lack of interaction between smoking and
exposure to hardwood dust on the risk of nasal cancer.
Increases in risk were restricted to carcinoma of the
nasal cavity and of the paranasal sinuses. We could also
confirm no increase in risk with exposure to softwood
dust, as others have shown repeatedly. We found
increased risks for adenocarcinomas only, as reported by
other researchers. It is interesting that in none of the
recent case–control studies [31,33] wood dust has been
analyzed by its origin (hardwood, softwood, chipboard).
Organic solvents
Exposure to organic solvents in our study emerged as a
consistent risk factor for carcinoma of the nasal cavities.
An analysis by tertiles of exposure years indicated abimodal distribution, as only the first and third tertiles
showed significantly increased ORs (1.57, 95% CI 1.03–
2.38 and 1.75, 95% CI 1.19–2.58, respectively). A similar
finding was reported by Hildesheim and co-authors [31]
in a case–control study on carcinoma of the nasophar-
ynx. For an exposure time of less than 10 years, they
reported an OR of 1.5 (95% CI 0.99–2.3) and no risk
increase with longer exposure periods (OR 0.93, 95% CI
0.61–1.4).
Asbestos
Exposure to asbestos was a strong risk factor for carcin-
oma of the paranasal sinuses and of the nasopharynx in
ever-smokers, but not in never-smokers. Maximum risk
was found in the third tertile of exposure years for
malignancies of the paranasal sinuses (OR 5.37, 95% CI
1.18–24.36). The increase in risk per year of exposure in
our study was 6% (95% CI 0–13%) for malignancies
of the paranasal sinuses and 5% (95% CI 1–10%) for
malignancies of the nasopharynx. In a pooled analysis of
12 case–control studies on sinonasal cancers, Luce and
co-authors [35] found inconsistent results, as men with
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the largest ORs. However, the authors had not included
smoking as a potential confounder nor did they stratify by
smoking status. To emulate the analysis conducted by Luce
and co-authors, we dropped pack-years of cigarettes
smoked from our full model on paranasal sinus carcinoma
and found slightly increased risk for tertiles of exposure (in
the 3rd tertile OR 2.46, 95% CI 1.11–5.45 vs. 2.36, 95% CI
1.00–5.57, with inclusion of pack-years as a confounder). It
is our opinion that this finding should lead to a cautious in-
terpretation of confounding in the case of strong risk fac-
tors, e.g., smoking.
Use of insecticides in homes
An increased risk associated with use of insecticides in
homes, as found in our study, has not been described in any
of the published studies. Brinton and co-authors [5] found
an OR of 1.41 for the combined application of insecticides,
pesticides, and herbicides in men. Zou and co-authors [36]
reported a non-significant increase in risk of NPC after use
of pesticides (OR 1.6, 95% CI 0.9–2.8), whereas Zhu and co-
authors [20] found a strong impact of pesticide use on sino-
nasal malignancies (OR 5.9, 95% CI 1.5–23.7). A recent in-
vestigation of Tisch and co-workers [37] offered a plausible
pathophysiologic explanation for our findings, as a variety of
insecticides (pentachlorophenol, lindane, transfluthrin, cyflu-
thrin and natural pyrethrum) showed strong genotoxic
effects when applied to isolated mucosal cells from inferior
and middle nasal conchae. The increase in risk was
restricted to never-smoking men. This is in contrast to find-
ings for other risk factors where risk increases in smokers
were larger than in never-smokers. However, when analyzing
the prevalence of never-smoking and of use of insecticides
in homes by educational attainment, both characteristics
were greatest in best-educated men.Table 8 Analysis of potential bias of 134 next-of-kin interview
Prevalence (%) in interv
Case
Educational attainment
Primary school or less 66.6
Secondary school 18.4
College 15.0
Use of tobacco products
Smoking (ever) 66.9
Nasal snuff (ever) 6.25
Exposures
Exposure to hardwood dust 12.9
Exposure to asbestos (ever) 15.4
Exposure to solvents (ever) 35.5
Residential use of insecticides 17.8
Nasal lavage/nasal sprays 11.3Analysis of potential biases
Biased estimates for exposures in case–control studies
may arise from differing responses of cases and controls
in interviews or likewise differing responses of cases or
controls and of next-of-kin. Next-of-kin interviews were
conducted in 134 of 427 cases (31%) and in 19 of 2401
controls (0.8%).
The results of an analysis of responses of cases and of
their proxies (Table 8) demonstrated that, except for
exposure to hardwood dust, there was no significant
difference in any of the major risk factors identified in
this case–control study. Assuming that there is under-
reporting of hardwood dust exposure by next-of-kin, this
would lead to an underestimate of the actual OR.
A biased estimate of exposures comparing cases and
controls could be expected if there was common know-
ledge of the effect of a potential risk factor for the dis-
ease under investigation. Such knowledge could induce
cases to attribute their disease to the risk factor, whereas
controls would respond indifferently.
Regarding the relevant risk factors investigated in this
case–control study, there was no widely available infor-
mation linking these risk factors to nasal carcinomas.
Moreover, questions regarding these risk factors were
embedded in a multitude of other questions. None of
these questions hinted at a connection with disease.
There was a markedly different distribution of educa-
tional attainment in cases vs. controls (Table 1). If this
reflected a selective difference between controls and
cases, it could lead to biased risk estimates. There are,
however, two arguments to refute such an assumption.
First, a lower response rate in cases than in controls
would lead to a higher proportion of respondents with
better educational attainment. This argument is based
on findings reached during the conduct of the firsts in 427 cases












Table 9 Odds ratios of risk factors stratified by educational attainment
Risk factor Educational attainment
Elementary school Secondary school College
Smoking* 1.066 (1.053–1.80) 1.050 (1.026–1.075) 1.030 (0.994–1.068)
Use of nasal snuff* 1.008 (1.0–1.018) 0.84 (0.17–4.08) 0.985 (0.948–1.023)
Exposure to asbestos* 1.023 (1.002–1.044) 1.017 (0.959–1.078) 0.867 (0.648–1.161)
Exposure to hardwood dust* 1.040 (1.021–1.059) 1.004 (0.875–1.153) 0.955 (0.738–1.235)
Exposure to solvents* 1.017 (1.005–1.029) 1.00 (0.962–1.04) 1.042 (0.994–1.068)
Domestic use of insecticides (ever) 1.21 (0.77–1.90) 1.61 (0.66–3.91) 3.86 (1.53–9.70)
Use of nasal lavage/nasal sprays* 1.003 (0.968–1.039) 1.052 (0.990–1.117) 0.968 (0.882–1.062)
* Per 1 year of exposure to asbestos, hardwood dust, organic solvents, per 1 pack-year of cigarettes, 1 package-year of nasal snuff, 1 month of use of nasal
lavage/spray for 1 year.
Adjustments for age, community size and for all other risk factors (duration of exposure or pack-years/package-years respectively, if appropriate).
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1985), where interim analyses conducted at increasing
levels of response rates showed increasing proportions
of participants with lower educational attainment, below
average income, without jobs, being smokers or over-
weight.a
Second, most of the established carcinogens tend to be
linked either to occupations that require less educational
attainment or to lifestyle habits more often found in less
well-educated people. Thus, it has to be expected that
the educational attainment of cases would reflect expo-
sures and individual risk factors that are more promin-
ent in these social groups. In consequence, more cases
would be expected in men with less education. An ana-
lysis, stratified by educational attainment (Table 9), con-
firmed that ORs for tobacco use as well as for exposure
to asbestos, hardwood dust and organic solvents were
greatest in the least educated men.
Strengths and limitations of the study
A major limitation of our study is the relatively small
response rate in cases, i.e., 55% vs. 62% in controls. Usu-
ally one would expect higher response rates in cases, but
as the recruitment of cases in our study was carried out
by staff of tumor registries or of ENT departments, not
by members of our study group, no attempts to encour-
age participation could be undertaken. With an increase
in response rate an increased proportion of persons
exposed to specific risk factors could be expected, and
a lower response rate in cases could lead to smaller
risk estimates.
Another shortcoming of our study was the retrospect-
ive recruitment of cases. As all malignancies included in
our study are rather rare, prospective recruitment would
most certainly have resulted in fewer deceased cases
than encountered with the present retrospective design,
but the study would not have been feasible owing to an
extremely long prospective recruitment period required.
Our study is the first study to deal with the impact of
nasal snuff on nasal cancer in an industrialized country.Thus the results regarding nasal snuff need confirmation
by future studies.
There are several strengths of our study. It was a rela-
tively large population-based case–control study. More-
over, the possibility of stratifying the analyses by
smoking status indicated that smoking, besides being a
risk factor itself, could act as a potent modifier for other
risk factors.
Conclusions
The results from our study confirm the role of smoking
and exposure to hardwood dust and asbestos as carcino-
gens for nasal carcinoma. In addition, we found increased
risks associated with exposure to organic solvents. Use of
insecticides in homes is suggested as a potential new risk
factor. Exposure to nasal snuff or asbestos dust leads to
an increased risk, mostly in past and current smokers. In
nearly all the analyses, increases in risk were more prom-
inent in smokers than in non-smokers.
Ethical Review Committees
The study design has been approved by the Ethical
Review Committees of the Bremen State Chamber of
Physicians, of the Bavarian State Chamber of Physicians,
of the Baden-Württemberg State Chamber of Physicians,
of the Augsburg Central Hospital, and of the Tübingen
University Hospital.
Endnotes
aThe first author of this paper was chairman of the
German Cardiovascular Prevention Study. The National
Health Examination Surveys provided reference data for
community-based preventions, conducted in 6 different
communities throughout Germany.
Abbreviations
CI: Confidence interval; CNC: Cancers of the nasal cavity; CPNS: Cancers of
the paranasal sinuses; ENT: Ear, nose and throat; NPC: Nasopharyngeal
cancer; OR: Odds ratio. One packyear, referring to cigarette smoking, is
equivalent of smoking of one pack of cigarettes per day for one year. One
package-year, referring to use of nasal snuff, is equivalent for the use of one
package of nasal snuff per week for one year.
Greiser et al. BMC Cancer 2012, 12:506 Page 11 of 12
http://www.biomedcentral.com/1471-2407/12/506Competing interest
The study was financed in full by Pöschl Tabak GmbH & Co KG,
Geisenhausen, Germany. The contract for the conduct of the study with E.G.
was signed after Dr. Pöschl, CEO of Pöschl Tabak GmbH & Co KG, had
agreed to the following terms: 1. no interference with design, conduct,
analysis, publication of study results; 2. establishment of an independent
scientific advisory board; 3. conduct of a pilot study. Throughout the entire
study these terms have been strictly adhered to. The authors declare no
conflict of interest.
Authors’ contribution
EMG designed the study, developed the study protocol, provided all of the
statistical analyses, wrote the first and the final version of the manuscript.
KHG revised the first and subsequent versions of the manuscript. WA
organized and oversaw the conduct of interviews, revised the first and
subsequent versions of the manuscript. RH, RL, BS and HPZ contributed
patients as cases for the study and revised the manuscript. HM contributed
to the final version of the study protocol, re-classified histo-pathologic
findings of all cases and contributed to revisions of the manuscript. All
authors read and approved the final manuscript.
Authors’ information
EMG, MD, PhD, is Professor emeritus for medical statistics and epidemiology,
Faculty of Health Sciences, Bremen University, Bremen Germany. He is
currently member of the Department of Health Economics, Health Policy
and Health Care Research, Center for Health Policy Research, Bremen
University, and CEO of Epi. Consult GmbH, Musweiler, Germany. KHG, MD,
MPH, is senior research fellow at the Department of Cancer Epidemiology,
German Cancer Research Centre, Heidelberg, Germany. WA, PhD, is Director
of the Department of Epidemiologic Methods and Etiologic Research, BIPS
Institute for Epidemiology and Prevention Research, and Deputy Director of
BIPS, Bremen University, Bremen, Germany.
RH, MD, PhD, is director of the Department of Otorhinolaryngology,
University of Wuerzburg, Wuerzburg, Germany. RL, MD, PhD, is director of
the Department of Otorhinolaryngology – Head and Neck Surgery, Albert-
Ludwigs University Medical School, Freiburg, Germany. HM, MD, PhD, is
director of the Department of Otorhinolaryngology, Head and Neck Surgery,
Bundeswehr Hospital, Ulm, Germany. Bernhard Schick, MD, PhD, is director of
the Department of Otorhinolaryngology, Saarland University, Homburg/Saar,
Germany. HPZ, MD, PhD, is director of the Department of Otolaryngology,
University of Tübingen, Tübingen, Germany.
Contributing ENT hospitals and tumour registries (key persons)
Tumour registries Tumorregister München des Tumorzentrums München
(Prof. Dr. Dieter Hölzel), München, Germany, Tumorzentrum Regensburg –
Epidemiologisches Krebsregister (Prof. Dr. Ferdinand, Hofstädter, Dr. Sabrina
Klinkhammer-Schalke), Regensburg, Germany, Tumorzentrum Erlangen –
Bevölkerungsbezogene Krebsregistrierung für, Mittelfranken (Prof. Dr.
Heinrich Iro, Dr. Sabrina Petsch), Erlangen, Germany.
ENT hospitals
Klinikum der Universität München - Klinik und Poliklinik für Hals-, Nasen und,
Ohrenkrankheiten (Prof. Dr. med. Alexander Berghaus), München, Germany,
Technische Universität München - Klinikum rechts der Isar – Hals-, Nasen-
Ohrenklinik und Poliklinik (Prof. Dr. W. Arnold), München, Germany,
Zentralklinikum Augsburg – HNO-Klinik (Prof. Dr. Franz Xaver Brunner),
Ausgburg, Germany, Universitätsklinikum Würzburg – Klinik und Poliklinik für
Hals-, Nasen- und, Ohrenkranke (Prof. Dr. Jan Helms), Würzburg, Germany,
Katharinenhospital Stuttgart – Hals-Nasen- Ohrenklinik (Prof. Dr. Rudolf
Hagen), Stuttgart, Germany, Klinikum der Universität Regensburg – HNO-
Klinik (Prof. Dr. Jürgen Strutz), Regensburg, Germany, Universitätsklinikum
Erlangen - Hals-Nasen-Ohrenklinik – Kopf- und Halschirurgie, (Prof. Dr.
Heinrich Iro), Erlangen, Germany, Klinikum Nürnberg – Hals-Nasen-
Ohrenklinik (Prof. Dr. Jürgen Theissing, Prof. Dr. Viktor Bonkowsky),
Universitätsklinikum Heidelberg – Hals-Nasen-Ohrenheilkunde, (Prof. Dr. Peter
K. Plinkert, PD Dr. A. Dietz), Heidelberg, Germany, Universitätsklinikum
Freiburg – Universitätsklinik für Hals-, Nasen- und, Ohrenheilkunde (Prof. Dr.
Dr.h.c. Roland Laszig), Freiburg, Germany, Universitätsklinikum Freiburg –
Zahn-, Mund- und Kieferheilkunde – Klinik und, Poliklinik für Mund-, Kiefer-
und Gesichtschirurgie (Prof. Dr. Dr. Rainer, Schmelzeisen), Freiburg,
GermanyvUniversitätsklinikum Ulm – Hals- Nasen- und Ohrenheilkunde (Prof.Dr. Gerhard, Rettinger), Ulm, Germany, Universitätsklinikum Tübingen –
Universitätsklinik für Hals,- Nasen- und, Ohrenheilkunde (Prof. Dr. Dr.h.c.mult.
Hans Peter Zenner), Tübingen, Germany, Klinikum im Haus Gesundbrunnen
Heilbronn – Klinik für Hals-Nasen-Ohrenkrankheiten und plastische Chirurgie
(Prof. Dr. Claus Naumann), Heilbronn, Germany.Scientific Advisory Board
Prof. Dr. Jenny Chang-Claude (Chair), German Cancer Research Center,
Department of Clinical Epidemiology, Heidelberg, Germany, Prof. Dr. Karl-
Heinz Jöckel, Institute for Medical Informatics, Biostatistics and Epidemiology,
Essen University Hospital, Essen, Germany, Prof. Dr. Heinz Maier, ENT
Department, Armed Forces Hospital, Ulm, Germany, Prof. Dr. Uwe John,
Institute for Epidemiology and Social Medicine, Ernst-Ludwig-Arndt
University, Greifswald, Germany.
Author details
1Center for Social Policy Research, Faculty of Health Sciences, Bremen
University, Bremen, Germany. 2Epi.Consult GmbH Ortsstr. 1 A, 54534,
Musweiler, Germany. 3Bremen Institute for Prevention Research and Social
Medicine (BIPS), Bremen University (until 3-2004), Bremen, Germany. 4German
Cancer Research Center, Division of Cancer Epidemiology, Heidelberg,
Germany. 5BIPS - Institute for Epidemiology and Prevention Research,
Bremen, Germany. 6Institute for Statistics, Bremen University, Bremen,
Germany. 7Department of Otorhinolaryngology, University of Wuerzburg,
Wuerzburg, Germany. 8Department of Otorhinolaryngology-Head and Neck
Surgery, Albert-Ludwigs University Medical School, Freiburg, Germany.
9Department of Otorhinolaryngology, Head and Neck Surgery, Bundeswehr
Hospital, Ulm, Germany. 10Department of Otorhinolaryngology, Saarland
University, Homburg/Saar, Germany. 11Department of Otolaryngology,
University of Tübingen, Tübingen, Germany.
Received: 29 April 2012 Accepted: 30 October 2012
Published: 6 November 2012References
1. ARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans:
Vol. 89. Smokeless tobacco and some tobacco-specific N-nitrosamines. Lyon;
2007.
2. SCENIRH: European Commission. DG Health and Consumer Protection.
Brussels: Scientific Committee on Emerging and Newly Identified Health
Risks. Public consultation. SCENIRH opinion on the health effects of
smokeless tobacco products; 2008.
3. Shapiro MP, Keen P, Cohen L, De Moor NG: Malignant disease in the
Transvaal. III. Cancer of the respiratory tract. S Afr Med J 1955, 29:95–101.
4. Acheson ED, Cowdell RH, Jolles B: Nasal cancer in the Northamptonshire
boot and shoe industry. Br Med J 1970, 1:385–393.
5. Brinton LA, Blot WJ, Becker JA, et al: A case–control study of cancer of the
nasal cavity and paranasal sinuses. Am J Epidemiol 1984, 119:896–906.
6. Stockwell HG, Lyman GH: Impact of smoking and smokeless tobacco on
the risk of cancer of the head and neck. Head Neck Surg 1986, 9:104–110.
7. Feng BJ, Khyatti M, Ben-Ayoub W, et al: Cannabis, tobacco and domestic
fumes intake are associated with nasopharyngeal carcinoma in North
Africa. Br J Cancer 2009, 101:1207–1212.
8. Chelleng PK, Narain K, Das KH, et al: Risk factors for cancer nasopharynx:
A case–control study from Nagaland, India. Nat Med J India 2000, 13:6–8.
9. Elwood M: Wood exposure and smoking: Association with cancer of the
nasal cavity and paranasal sinuses in British Columbia. Can Med Ass J
1981, 124:1573–1577.
10. Hayes RB, Kardaun JWPF, de Bruyn A: Tobacco use and sinonasal cancer; a
case–control study. Br J Cancer 1987, 56:843–846.
11. Fukuda K, Shibata A, Harada K: Squamous cell cancer of the maxillary
sinus in Hokkaido, Japan: A case–control study. Br J Ind Med 1987,
44:263–266.
12. Yu MC, Garabrant DH, Huang TB, Henderson BE: Occupational and other
non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou,
China. Int J Cancer 1990, 45:1033–1039.
13. West S, Hildesheim A, Dosemeci M: Non-viral risk factors for
nasopharyngeal carcinoma in the Philippines: results from a
case–control study. Int J Cancer 1993, 55:722–727.
Greiser et al. BMC Cancer 2012, 12:506 Page 12 of 12
http://www.biomedcentral.com/1471-2407/12/50614. Nam J, McLaughlin JK, Blot WJ: Cigarette smoking, alcohol and
nasopharyngeal carcinoma: a case–control study among US whites.
JNCI 1992, 84:619–622.
15. Zheng W, McLaughlin JK, Chow WH, Chien HT, Blot WJ: Risk factors for
cancers of the nasal cavity and paranasal sinuses among white men in
the United States. Am J Epidemiol 1993, 138:965–972.
16. Zhu K, Levine RS, Brann EA, Gnepp DR, Baum MK: A population-based
case–control study of the relationship between cigarette smoking and
nasopharyngeal cancer (United States). Cancer Causes Control 1995,
6:507–512.
17. Cheng YJ, Hildesheim A, Hsu MM, et al: Cigarette smoking, alcohol
consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer
Causes Control 1999, 10:201–207.
18. Caplan LS, Hall HI, Levine RS, Zhu K: Preventable risk factors for nasal
cancer. Ann Epidemiol 2000, 10:186–191.
19. Yuan JM, Wang XL, Xiang YB, et al: Non-dietary risk factors for
nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000,
85:364–369.
20. Zhu K, Levine RS, Brann EA, et al: Case–control study evaluating the
homogeneity and heterogeneity of risk factors between sinonasal and
nasopharyngeal cancers. Int J Cancer 2002, 99:119–123.
21. Ekburanawat W, Ekpanyaskul C, Brennan P, et al: Evaluation of non-viral
risk factors for nasopharyngeal carcinoma in Thailand: results from a
case–control study. Asian Pac J Cancer Prev 2010, 11:929–932.
22. Ji X, Zhang W, Xie C, et al: Nasopharyngeal carcinoma risk by histologic
type in central China: impact of smoking, alcohol, and family history.
Int J Cancer 2011, 129:724–732.
23. Wynder EL, Hultberg S, Jacobsson F, et al: Environmental factors in
cancer of the upper alimentary tract. A Swedish study with special
reference to Plummer-Vinson (Paterson-Kelley) Syndrome. Cancer 1957,
10:470–487.
24. Shimizu H, Hozawa J, Saito H, et al: Chronic sinusitis and woodworking as
risk factors for cancer of the maxillary sinus in Northeast Japan.
Laryngoscope 1989, 99:58–61.
25. International Agency for Research on Cancer: IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of
Carcinogenicity: an Updating of IARC Monographs Volumes 1-42. Supplement
7, Lyon: 1987, 380–382.
26. International Agency for Research on Cancer: IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans. Monograph Volume 62. Lyon:
Wood Dust and Formaldehyde; 1995:35–216.
27. Blot WJ, Chow WH, McLaughlin JK: Wood dust and nasal cancer risk. A
review of the evidence from North America. J Occup Environ Med 1997,
39:148–156.
28. Hayes RB, Raatgever JW, de Bruyn A, et al: Cancer of the nasal cavity and
paranasal sinuses, and formaldehyde exposure. Int J Cancer 1986,
37:487–492.
29. Armstrong RW, Imrey PB, Lye MS, et al: Nasopharyngeal carcinoma in
Malayan Chinese: occupational exposures to particles, formaldehyde and
heat. Int J Epidemiol 2000, 29:991–998.
30. Hayes RB, Gerin M, Raatgever JW, et al: Wood related occupations,
wood dust exposure, and sinonasal cancer. Am J Epidemiol 1986,
124:569–577.
31. Hildesheim A, Dosemeci M, Chan CC, et al: Occupational exposure to
wood, formaldehyde, and solvents and risk of nasopharyngeal
carcinoma. Cancer Epidemiol Biomarkers Prev 2001, 10:1145–1153.
32. Luce D, Gérin M, Leclerc A, Morcett JF, Brugère J, Goldberg M: Sinonasal
cancer and occupational exposure to formaldehyde and other
substances. Int J Cancer 1993, 53:224–231.
33. Pesch B, Pierl CB, Gebel M, et al: Occupational risk for adenocarcinoma of
the nasal cavity and paranasal sinuses in the German wood industry.
Occup Environ Med 2008, 65:191–196.
34. Comba P, Battista G, Belli S, et al: A case–control study of cancer of the
nose and paranasal sinuses and occupational exposures. Am J Ind Med
1992, 22:511–520.
35. Luce D, Leclerc A, Begin D, et al: Sinonasal cancer and occupational
exposure: a pooled analysis of 12 case–control studies. Cancer Causes
Control 2002, 13:147–157.36. Zou J, Sun Q, Akiba S, et al: A case–control study of nasopharyngeal
carcinoma in the high background radiation areas of Yangyiang, China.
J Radiat Res 2000, 41:53–62.
37. Tisch M, Faulde MK, Maier H: Genotoxic effects of pentachlorophenol,
lindane, transfluthrin, cyfluthrin and natural pyrethrum on human
mucosal cells of the inferior and middle nasal conchae. Am J Rhinol 2005,
19:141–151.
doi:10.1186/1471-2407-12-506
Cite this article as: Greiser et al.: Risk factors for nasal malignancies in
German men: the South-German Nasal cancer study. BMC Cancer 2012
12:506.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
